Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, placebo-controlled trial will assess the effects of
twice-daily subcutaneous injection with exenatide versus treatment with matching placebo
injection on abdominal visceral fat content.